Immune Design Corp (IMDZ.OQ)
IMDZ.OQ on NASDAQ Stock Exchange Global Market
1.66USD
4:23pm BST
1.66USD
4:23pm BST
Change (% chg)
$-0.05 (-2.92%)
$-0.05 (-2.92%)
Prev Close
$1.71
$1.71
Open
$1.70
$1.70
Day's High
$1.72
$1.72
Day's Low
$1.61
$1.61
Volume
74,230
74,230
Avg. Vol
45,833
45,833
52-wk High
$11.05
$11.05
52-wk Low
$1.48
$1.48
About
Immune Design Corp. is a clinical-stage immunotherapy company. The Company is focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. The Company has engineered its technologies to activate the immune system's natural ability to create tumor-specific cytotoxic T cells (CTLs) to... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $269.01 |
| Shares Outstanding(Mil.): | 25.62 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| IMDZ.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 86.20 | 32.69 |
| EPS (TTM): | -2.20 | -- | -- |
| ROI: | -66.38 | 0.73 | 14.32 |
| ROE: | -66.44 | 1.82 | 16.04 |
BRIEF-Immune Design Q1 Loss Per Share $0.28
* IMMUNE DESIGN REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Estimates